The Only Anticoagulant Product Approved by the United States Food & Drug Administration

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, USP (2.13% free citrate ion), is a sterile, non-pyrogenic solution. ACD-A is the only anticoagulant product approved by the United States Food & Drug Administration (FDA) for the use in Autologous PRP Systems for the preparation of Platelet-Rich Plasma (PRP).

Procedures

  • Multiple

Application

  • Autologous PRP

Product Features

Technology

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, USP (2.13% free citrate ion), is a sterile, non-pyrogenic solution.

Citrate-based anticoagulants prevent the coagulation of blood by virtue of the citrate ion's ability to chelate ionized calcium present in the blood to form a non-ionized calcium-citrate complex.

Benefits

Anticoagulant approved by the FDA

  • ACD-A is the only anticoagulant product approved by the United States Food and Drug Administation (FDA) for the use in Autologous PRP Systems for the preparation of Platelet-Rich Plasma (PRP).

Safety Information

Indications 

  • Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A) is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous Platelet-Rich Plasma (PRP) Systems in production of PRP.

Warnings and Contraindications

  • ACD-A is not for direct intravenous infusion.

Adverse Reactions

  • Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Additional Information

Tailored resources for your patients.

Find videos, articles, and interactive content to guide your patients throughout their surgical journey on ReadyPatient.com, our dedicated patient recovery site.